This Cannabis Stock Can Rise 300% by 2023

With the power of Molson Coors Canada Inc. (TSX:TPX.B)(NYSE:TAP) behind it, HEXO Corp. (TSX:HEXO)(NYSE:HEXO) is capitalizing on cannabis opportunities that others are ignoring.

| More on:
Hand arranging wood block stacking as step stair with arrow up.

Image source: Getty Images

Legal pot is going to be huge. That’s a near certainty.

In the U.S., for example, black market cannabis sales were estimated to be US$64.3 billion in 2018. Legal sales, meanwhile, totaled just US$10.3 billion. Simply taking market share from illicit sales should fuel legal sales growth for a decade or more.

Additionally, legal cannabis has opened the floodgates to new users and use cases. New Frontier Data, a data and analytics firm focused on the cannabis industry, believes legal sales in the U.S. will nearly triple to US$29.7 billion by 2025. Notably, black market sales are still expected to be US$57.3 billion. That means the total market size in the U.S. could reach US$87 billion by 2025, up from US$74 billion today.

All of this is encouraging, but these numbers are still way too conservative. That’s because they don’t account for new cannabis segments like edibles, vaporizers, beverages, cosmetics, medicines, and more. When accounting for these opportunities, many cannabis projections can be tripled. Here’s why.

Consider the global alcohol market. Globally, alcohol sales total roughly $1.4 trillion. By 2025, they’re expected to surpass $1.6 trillion. Sales of cannabis-infused beverages, meanwhile, are virtually non-existent. To ignore this market opportunity is to write-off hundreds of billions of dollars in sales potential.

Investors and analysts aren’t the only ones ignoring adjacent markets for cannabis; companies are doing it too. Well, most are. There’s one Canadian pot stock that’s capitalizing on every cannabis opportunity imaginable. If you truly want to take advantage of the marijuana boom, this is the stock for you. On many metrics, shares could more than triple by 2023.

Building the infrastructure

Instead of focusing on a traditional cannabis model, which nearly every other competitor is doing, HEXO (TSX:HEXO)(NYSE:HEXO) is charting a different course.

If you’re not familiar with the power of platforming, get acquainted. This business model doesn’t focus on providing everything to its customers. Instead, it simply builds the base infrastructure, inviting other individuals and companies to build on top of it. As the name suggests, these companies only provide a platform.

In many ways, this business model is significantly more lucrative than being a complete end-to-end provider. Consider the Windows operating system from Microsoft. The thousands of mission-critical applications that were subsequently built on top of Windows weren’t pioneered by Microsoft. Instead, they were created and monetized by thousands of developers around the world, who used Windows as a base platform.

HEXO is building the world’s first cannabis platform. Instead of trusting itself to build everything from scratch, it’s simply assembling the basic infrastructure like grow facilities, research and development centres, and packaging and distribution hubs. It’s then inviting outside companies to use this platform to design, create, and scale their own products.

One such partner is Molson Coors Canada. In this case, HEXO can leverage Molson’s existing brand power, eliminating the need to build an upstart brand from scratch. Molson, meanwhile, can create safe and effective cannabis products quickly, without needing to scale up its own marijuana infrastructure.

This month, the Molson-HEXO partnership expects to release its first cannabis-infused beverages in Canada, beating nearly every competitor to market. Globally, cannabis-infused beverages could eventually generate $100 billion in sales, just as much as traditional cannabis form factors. Molson and HEXO have a big lead.

In 2020, HEXO wants to establish more partnerships targeting additional adjacent cannabis markets like edibles, sleep aids, cosmetics, and more. Its platform model allows it to acquire globally recognized brands and bring products to market faster than any of its peers.

Wherever there is opportunity, HEXO is prepared to strike. You can’t say that about any other cannabis stock.

Next year, sales are expected to approach $200 million. By 2023, they could approach $1 billion. That would still represent just a small fraction of the overall market’s size. Given current valuation multiples, HEXO stock could have 300% upside by 2023 if its platform model continues to gain traction.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool’s board of directors. The Motley Fool owns shares of and recommends Microsoft. The Motley Fool owns shares of Molson Coors Brewing. The Motley Fool recommends HEXO. and HEXO and recommends the following options: long January 2021 $85 calls on Microsoft. Fool contributor Ryan Vanzo has no position in any stocks mentioned. 

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »